INTEGRATED BIOPHARMA INC - FORM 10-K - EX-21 - EXHIBIT 21 SUBSIDIARIES OF THE REGISTRANT - September 23, 2020

Attached files

file	filename
EX-32.2 - EXHIBIT 32.2 CERTIFICATION OF CFO PURSUANT TO 18 USC - INTEGRATED BIOPHARMA INC	ex_202529.htm
EX-32.1 - EXHIBIT 32.1 CERTIFICATION OF CEO PURSUANT TO 18 USC - INTEGRATED BIOPHARMA INC	ex_202528.htm
EX-31.2 - EXHIBIT 31.2 CERTIFICATION OF CFO - INTEGRATED BIOPHARMA INC	ex_202527.htm
EX-31.1 - EXHIBIT 31.1 CERTIFICATION OF CEO - INTEGRATED BIOPHARMA INC	ex_202526.htm
EX-23.1 - EXHIBIT 23.1 CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM - INTEGRATED BIOPHARMA INC	ex_202530.htm
EX-10.221 - EXHIBIT 10.22.1 AMENDMENT TO PAYCHECK PROTECTION PROGRAM TERM NOTE - INTEGRATED BIOPHARMA INC	ex_204539.htm
10-K - FORM 10-K - INTEGRATED BIOPHARMA INC	inbp20200630_10k.htm

EXHIBIT 21

INTEGRATED BIOPHARMA, INC. AND SUBSIDIARIES

SUBSIDIARIES OF THE REGISTRANT

Subsidiary Name	State of Incorporation

Manhattan Drug Company, Inc.	New Jersey
AgroLabs, Inc.	New Jersey
IHT Health Products, Inc.	Delaware
Vitamin Factory, Inc.	Delaware
IHT Properties, Inc.	Delaware
MDC Warehousing and Distribution, Inc. (f/k/a The Organic Beverage Company)	New Jersey
InB:Paxis Pharmaceuticals, Inc. (f/k/a Paxis Pharmaceuticals, Inc.) - inactive	Delaware